Simon Dingemans is Managing Director and a Senior Member of the Carlyle Advisory Team at The Carlyle Group. He is responsible for UK buyouts and healthcare deals across Europe.
Previously, Simon was Chief Financial Officer of GlaxoSmithKline for over eight years. At GSK he was a member of the Board and Corporate Executive Team (CET), and was directly involved in developing and delivering the strategy of the Company and driving its operational performance. As CFO he was responsible for leading Finance and a variety of other group functions, including Real Estate and Procurement, Technology and IT.
Before joining GSK, Mr. Dingemans was an investment banker for 25 years. He spent the first ten years of his career at S.G. Warburg, starting as a graduate trainee, before moving to Goldman Sachs in 1995. Over 15 years with Goldman Sachs, Including 10 years as a Partner of the Firm, he ran UK investment banking and was a leader of its European Mergers and Acquisitions business. During his time at Goldman Sachs, he came to be one of the most prolific and respected Mergers and Acquisitions...Simon Dingemans is Managing Director and a Senior Member of the Carlyle Advisory Team at The Carlyle Group. He is responsible for UK buyouts and healthcare deals across Europe.
Previously, Simon was Chief Financial Officer of GlaxoSmithKline for over eight years. At GSK he was a member of the Board and Corporate Executive Team (CET), and was directly involved in developing and delivering the strategy of the Company and driving its operational performance. As CFO he was responsible for leading Finance and a variety of other group functions, including Real Estate and Procurement, Technology and IT.
Before joining GSK, Mr. Dingemans was an investment banker for 25 years. He spent the first ten years of his career at S.G. Warburg, starting as a graduate trainee, before moving to Goldman Sachs in 1995. Over 15 years with Goldman Sachs, Including 10 years as a Partner of the Firm, he ran UK investment banking and was a leader of its European Mergers and Acquisitions business. During his time at Goldman Sachs, he came to be one of the most prolific and respected Mergers and Acquisitions bankers in Europe advising on some of the largest and most complex transactions valued at over $500 billion in aggregate.
Simon served as Non-Executive Chair of the Financial Reporting Council, the audit regulator, from October 2019 until May 2020. He also previously served as Chairman of the 100 Group which represents the views of the Finance Directors of FTSE 100 and a number of large UK private companies. Simon is currently a trustee of the Donmar Warehouse Theatre. He holds a Master's degree in Geography from Oxford University.moreless
Simon Dingemans, Managing Director at The Carlyle Group, is mentioned in Bloomberg regarding Carlyle's recent acquisition of Vectura Group Plc for $1.4 billion.
Founded in 1987, The Carlyle Group is a multinational private equity, financial services, and alternative asset management firm. Since, it has grown to include 32 offices across six continents, faithfully adhering to its mission of inspiring the confidence and loyalty of investors.
The FRC set the UK’s Corporate Governance and Stewardship Codes and regulates accountants, auditors and actuaries. The FRC is due to be replaced by a new regulator – the Audit, Reporting and Governance Authority (ARGA).
GlaxoSmithKline is a pharmaceutical company which consists of three global businesses. It focuses on research, developing and manufacturing innovative pharmaceutical vaccines, medicines and consumer healthcare products.
Goldman Sachs is a worldwide investment banking, investment management, securities, and other financial services firm headquartered in New York City.
S. G. Warburg & Co. LTD.
Director
Sep 1985 - Jun 1995
London, UK
S.G. Warburg & Company was an investment bank based in London. In the 1960’s it was recognised for its pioneering merger and takeover work in the UK, it then grew rapidly for the following 20 years before merging with Swiss Bank Corporation in 1995.
The 100 Group represents the views of the Finance Directors of FTSE 100 and a number of large UK private companies. It is organised through a structure of committees, who meet regularly to debate emerging topics on the agenda of Finance Directors.
